Literature DB >> 28203445

Epidermal growth factor receptor-targeted poly(amidoamine)-based dendrimer complexed oncolytic adenovirus: is it safe totally?

Min Huang1, Chun-Sheng Yang2, Yong Xin1, Guan Jiang3.   

Abstract

Entities:  

Year:  2017        PMID： 28203445      PMCID： PMC5303085          DOI： 10.21037/jtd.2017.01.41

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  Cetuximab.

Authors:  Joanne Graham; Mohamed Muhsin; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2004-07       Impact factor: 84.694

2.  Nanoparticles and toxicity in therapeutic delivery: the ongoing debate.

Authors:  Sharif Hossain; Ezharul Hoque Chowdhury; Toshihiro Akaike
Journal:  Ther Deliv       Date:  2011-02

Review 3.  Evolution of oncolytic adenovirus for cancer treatment.

Authors:  Joung-Woo Choi; Jung-Sun Lee; Sung Wan Kim; Chae-Ok Yun
Journal:  Adv Drug Deliv Rev       Date:  2011-12-24       Impact factor: 15.470

4.  Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells.

Authors:  Pratap C Naha; Maria Davoren; Fiona M Lyng; Hugh J Byrne
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-24       Impact factor: 4.219

5.  Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia.

Authors:  Alice Bertero; Adriano Boni; Mauro Gemmi; Mariacristina Gagliardi; Angelo Bifone; Giuseppe Bardi
Journal:  Nanotoxicology       Date:  2013-01-30       Impact factor: 5.913

6.  Effect of poly(amidoamine) dendrimers on the structure and activity of immune molecules.

Authors:  Jiansheng Lin; Wenxi Hua; Yi Zhang; Chenghua Li; Wei Xue; Jian Yin; Zonghua Liu; Xiaozhong Qiu
Journal:  Biochim Biophys Acta       Date:  2014-11-24

7.  Antitumor effect and safety profile of systemically delivered oncolytic adenovirus complexed with EGFR-targeted PAMAM-based dendrimer in orthotopic lung tumor model.

Authors:  A-Rum Yoon; Dayananda Kasala; Yan Li; Jinwoo Hong; Wonsig Lee; Soo-Jung Jung; Chae-Ok Yun
Journal:  J Control Release       Date:  2016-03-04       Impact factor: 9.776

Review 8.  Recent advances in oncolytic adenovirus therapies for cancer.

Authors:  Amanda Rosewell Shaw; Masataka Suzuki
Journal:  Curr Opin Virol       Date:  2016-07-02       Impact factor: 7.090

9.  Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells.

Authors:  Jung-Sun Lee; Eonju Oh; Ji Young Yoo; Kyeong Sook Choi; Mi Jin Yoon; Chae-Ok Yun
Journal:  Oncotarget       Date:  2015-02-28
  9 in total
  1 in total

Review 1.  New Advances in General Biomedical Applications of PAMAM Dendrimers.

Authors:  Renan Vinicius de Araújo; Soraya da Silva Santos; Elizabeth Igne Ferreira; Jeanine Giarolla
Journal:  Molecules       Date:  2018-11-02       Impact factor: 4.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.